OPEXA THERAPEUTICS
Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology company dedicated to the development of patient-specific immunotherapies for the treatment of multiple sclerosis. The Company’s leading therapy candidate, Tcelna™, is a personalized T-cell immunotherapy in a Phase IIb clinical development program (the Abili-T trial) for the treatment of Secondary Progressive Multiple Sclerosis. Opexa’s mission is to lead the field of Precision Immunotherapy™ by aligning the interests of patients, employees and shareholders. Opexa is located in The Woodlands, Texas north of Houston on one acre of forested land and houses its cGMP facility, research laboratories and corporate offices.
OPEXA THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
1986-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.opexatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(281) 272-9331
Email Addresses:
[email protected]
Total Funding:
5.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Domain Not Resolving Apache Mobile Non Scaleable Content CPanel SSL One.com DNS SingleHop
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.opexatherapeutics.com
- Host name: cphost23.qhoster.net
- IP address: 104.243.33.214
- Location: Miami United States
- Latitude: 25.8119
- Longitude: -80.2318
- Metro Code: 528
- Timezone: America/New_York
- Postal: 33142
More informations about "Opexa Therapeutics"
About Opexa - About Opexa - Opexa Therapeutics
Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publically traded biotechnology company developing a personalized immunotherapy with the potential to treat major illnesses, including …See details»
Opexa Therapeutics
2/11/2021 - 2:30am EST "The 15th Annual BIO CEO & Investor Conference". 2/05/2022 - 8:30am EST Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for …See details»
Opexa Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number (281) 272-9331 Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology …See details»
Opexa Therapeutics Company Profile 2024: Valuation, Investors ...
Opexa Therapeutics General Information Description. Provider and developer of patient-specific cellular therapies intended for the treatment of autoimmune diseases. The company's …See details»
Opexa Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jun 20, 2023 Explore Opexa Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 4 news, Disease Domain:Nervous System Diseases ...See details»
Opexa Therapeutics - LinkedIn
Opexa Therapeutics | 1,198 followers on LinkedIn. Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology company dedicated to the development of personalized immunotherapies ...See details»
Opexa Therapeutics, Inc. - VentureRadar
Opexa Therapeutics, Inc. VentureRadar profile. Find out more about Opexa Therapeutics, Inc., Cell Therapies and Major Pharmaceuticals.See details»
Opexa Therapeutics - Company Profile - Tracxn
Oct 30, 2024 Opexa Therapeutics - Developing personalized T-cell therapies to treat autoimmune diseases, including multiple sclerosis.. Acquired by Acer Therapeutics. Raised a …See details»
Opexa Therapeutics
[email protected]. About Opexa. Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology company dedicated to the development of patient-specific …See details»
Opexa Therapeutics Management Team | Org Chart - RocketReach
Opexa Therapeutics employs 23 employees. The Opexa Therapeutics management team includes Marianne Pfeil (Quality Control Laboratory Technician), Maika Schuster (User …See details»
Opexa Therapeutics Inc. - life-sciences-europe.com
Upcoming Events. BMSS-BSPR Super Meeting 2024 Warwick (BMSS 2024) Morgan Stanley Global Healthcare Conference 2024 New York; Goldman Sachs European Medtech and …See details»
Opexa Therapeutics, Inc. (OPXA) Starts Presentation at 15th …
Feb 11, 2013 Opexa Therapeutics is a biotechnology company focused on developing patient-specific cellular therapies for treating autoimmune diseases like MS. Tcelna, the company’s …See details»
Opexa Initiates Discussions with Health Canada in Pre-CTA Meeting
Jun 2, 2011 For more information visit the Opexa Therapeutics website at www.opexatherapeutics.com. Cautionary Statement Relating to Forward - Looking Information …See details»
Opexa Therapeutics
Prior to joining Opexa, she was the Senior Vice President for Regulatory Affairs and Emerging Biotechnologies at inVentiv Clinical Solutions, LLC , a full-serve contract research …See details»
Opexa Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 2635 N Crescent Ridge Drive . The Woodlands, Texas, 77381, United States. 281-272-9331See details»
Opexa Strengthens Management Team with Hire of Cell Therapy …
Apr 27, 2010 Opexa Strengthens Management Team with Hire of Cell Therapy Expert VP of Scientific Development will lead Opexa's R&D efforts in Tovaxin® THE WOODLANDS, Texas- …See details»
Opexa Facility Becomes Foundation for Contract Manufacturing …
Feb 1, 2022 THE WOODLANDS, Texas (February 1, 2022) - Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company with a strong history of cellular therapy drug …See details»
Opexa Therapeutics, Inc. Announces $5.1 Million Securities Offering
Dec 10, 2009 For more information visit the Opexa Therapeutics website at www.opexatherapeutics.com. Cautionary Statement Relating to Forward - Looking Information …See details»
Opexa Therapeutics, Inc. - Cruelty Free Investing
Opexa Therapeutics, Inc. (Opexa), incorporated on March 15, 1991, is a biopharmaceutical company. The Company is engaged in the development of a personalized immunotherapy …See details»